Mitesh

Class 4 Medicines Defect Information: Pantoprazole 40 mg gastro-resistant tablets (Cadila Pharmaceuticals (UK) Limited) Drug alert number: EL (24)A/03 Date issued: 30 January 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Pantoprazole 40 mg gastro-resistant tablets (Cadila Pharmaceuticals (UK) Limited) Company name: Cadila Pharmaceuticals [...]

The post Class 4 Medicines Defect Information: Pantoprazole 40 mg gastro-resistant tablets (Cadila Pharmaceuticals (UK) Limited) appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 6 January 2024) has been published and includes articles on: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): new safety and educational materials to support regulatory  measures in men and women under 55 years [...]

The post MHRA Drug Safety Update: January 2024 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 125mg/5ml oral suspension are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP053 Clarithromycin 125mg/5ml oral suspension expires at 23.59pm on Friday 12 January 2024. After this date, any prescriptions for Clarithromycin 125mg/5ml oral suspension [...]

The post Expiry of SSP053 Clarithromycin 125mg/5ml oral suspension appeared first on Community Pharmacy England.

Date issued: 3 January 2024 The Food Standards Agency has issued a company-led medicines recall for: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula – Reckitt Benckiser Healthcare (UK) Ltd Company name: Reckitt Benckiser Healthcare (UK) Ltd Product name: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula Batch number/expiry Product name Batch number Expiry date [...]

The post Company Led Recall: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula – Reckitt Benckiser Healthcare (UK) Ltd appeared first on Community Pharmacy England.

To avoid any delays in payment for electronic prescriptions dispensed in December (Dispense Notification messages submitted by 31 December 2023), pharmacy owners are reminded to submit their corresponding electronic Claim Notification (CN) messages or Electronic Reimbursement Endorsement Messages (EREMs) no later than the 5 January 2024. However, with New Year’s Day (1 January 2024) occurring [...]

The post Reminder: Submit your EPS claims by 5 January and FP34Cs by 6 January appeared first on Community Pharmacy England.